kasabach-merritt syndrome - HEALTHY
Kasabach–Merritt syndrome (KMS), also known as hemangioma with thrombocytopenia, [1] is a rare disease, usually of infants, in which a vascular tumor leads to decreased platelet counts and sometimes other bleeding problems, [2] which can be life-threatening. [3] Kasabach-Merritt Syndrome (KMS) happens when a kaposiform hemangioendothelioma or a tufted angioma (two types of tumors) cause bleeding and clotting problems. They can lead to low platelets, low clotting proteins and low red blood cells.
Context Explanation
Kasabach-Merritt syndrome is characterized by profound thrombocytopenia in association with two rare vascular tumors: kaposiform hemangioendotheliomas and tufted angiomas. Kasabach-Merritt phenomenon (KMP), also known as Kasabach-Merritt syndrome (KMS), is a rare consumption coagulopathy specifically associated with two rapidly growing vascular tumors,... Kasabach-Merritt syndrome, also known as Kasabach-Merritt phenomenon, refers to blood-clotting problems that occur due to a rare, noncancerous tumor of the blood vessels. The condition can be a...
Image Collection
Insight Material
What causes Kasabach-Merritt syndrome? Kasabach-Merritt syndrome is caused by kaposiform haemangioendotheliomas, tufted angiomas, and sometimes other vascular tumours. Kasabach-Merritt syndrome, also known as hemangioma thrombocytopenia syndrome, is a rare life-threatening disease found mostly in infants in which a rapidly growing vascular tumor is responsible for thrombocytopenia, microangiopathic hemolytic anemia, and consumptive coagulopathy. Kasabach-Merritt Phenomenon (previously known as Kasabach-Merritt Syndrome) is a rare, rapidly growing vascular tumor capable of causing a life-threatening consumptive coagulopathy. Kasabach-Merritt phenomenon (KMP) is a rare, potentially life-threatening condition.
Related Articles You Might Like:
ernst & young entrepreneur of the year pictures of vulva with yeast infection normal blood pressure readings for menFinal Conclusion
It occurs when certain fast-growing vascular tumors [kaposiform hemangioendothelioma (KHE) or tufted angioma (TA)] trap and destroy platelets, interfering with blood clotting and raising the risk of serious bleeding. Kasabach-Merritt phenomenon (KMP) is a life-threatening thrombocytopenic coagulopathy associated with rare vascular tumors, such as kaposiform hemangioendothelioma (KHE), and less frequently with tufted angioma (TA).